openPR Logo
Press release

Antithrombin III Deficiency Testing Market Growth Dynamics over 2021

05-06-2018 06:44 AM CET | Health & Medicine

Press release from: Persistence Market Research

Antithrombin III Deficiency Testing Market Growth Dynamics

Antithrombin III is a non-vitamin, K-dependent protease that naturally blocks abnormal blood clot formation in the bloodstream. Deficiency of antithrombin III causes various blood clot disorders in the human body. For instance, congenital antithrombin III deficiency is a common antithrombin deficiency, which usually occurs when individuals receive the abnormal antithrombin III gene from their parents. This abnormal gene causes abnormal blood clots in the human body which block blood flow and damage organs.

Antithrombin deficiencies are mainly divided into two types: type I and type II. The type I antithrombin deficiency is characterized by an inadequate amount of normal antithrombin present in the bloodstream. In this condition, there is simply not enough antithrombin present to inactivate the coagulation factors. The type II antithrombin deficiency is characterized by adequate amount of antithrombin present in the bloodstream. However, it does not function properly and is unable to carry out its normal functions.

Request for Table of Contents @ https://www.persistencemarketresearch.com/toc/4272

The major symptoms of blood clotting include fainting, coughing up blood, shortness of breath, pain when taking deep breaths, and swelling of legs. In addition, some physical symptoms of blood clots are abnormal lung sounds, fast breathing, swollen foot or leg, and fast heart rate.

The global antithrombin III deficiency testing market is categorized on the basis of various types of deficiencies, diagnostic procedures, and end users. Based on the type of deficiencies, the report covers type I antithrombin deficiency and type II antithrombin deficiency. Based on the type of technology, the report covers monoclonal antibodies, molecular diagnostics, differential light scattering, immunoassays, flow cytometry, chromatography, gel micro droplets, diagnostic imaging, and others. Based on end users, the report covers commercial or private labs, physician offices, hospitals, public health labs, and academic research institutes.

In terms of geography, North America dominates the global antithrombin III deficiency testing market. This is due to increased government funding on healthcare infrastructure in the region. In addition, technological advancement in antithrombin III diagnostic procedures has also propelled the market in North America. The U.S. represents the largest market for antithrombin deficiency testing in North America, followed by Canada. In Europe, Germany, France, and the U.K. hold the major shares of the antithrombin III deficiency testing market. The antithrombin III deficiency testing market in Asia is also expected to show high growth rates in the next five years. This is due to the various initiatives undertaken by governments to increase awareness about blood clotting disorders in the region. In addition, increased investments by many foreign diagnostic instrument companies have also propelled the growth of the antithrombin III deficiency testing market in the region. India, China, and Japan are expected to be the fastest-growing markets for antithrombin III deficiency testing in Asia.

Advanced applications of antithrombin deficiency diagnostic instruments and increasing prevalence of blood clot disorders are the key drivers for the global antithrombin III deficiency testing market. Also, increased government support in the form of funding and rapid technological advancements have fueled the growth of this market.

An increasing number of mergers and acquisitions involving diagnostic consumables manufacturing companies and rapid product launches are the key trends in the global antithrombin III deficiency testing market.

Request a Sample Brochure of the Report @ https://www.persistencemarketresearch.com/samples/4272

The major companies operating in this market are Abbott Laboratories, Avocet Medical Inc., Axis-Shield plc, Beckman Coulter Inc., Becton, Dickinson and Company, Trinity Biotech PLC, Thermo Fisher Scientific, Inc., Siemens AG, Roche, Chrono-log Corporation, Sysmex Corporation, Hyphen Biomed and American Diagnostica GmbH.

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us

Persistence Market Research

305 Broadway

7th Floor, New York City,

NY 10007, United States,

Telephone - +1-646-568-7751

USA – Canada Toll Free: 800-961-0353

Email: sales@persistencemarketresearch.com

Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Antithrombin III Deficiency Testing Market Growth Dynamics over 2021 here

News-ID: 1040501 • Views:

More Releases from Persistence Market Research

Electric Golf Cart Market Outlook 2032: Key Players Include Yamaha, Club Car, E-Z-GO, Garia, and Polaris
Electric Golf Cart Market Outlook 2032: Key Players Include Yamaha, Club Car, E- …
The electric golf cart market is entering a transformative decade, shaped by sustainability goals, tourism expansion, and rapid advancements in battery performance. According to Persistence Market Research, the electric golf cart market is projected to reach US$2.6 billion in 2025 and further grow to US$4.1 billion by 2032, registering a healthy CAGR of 6.7% between 2025 and 2032. As clean mobility continues to influence both recreational and commercial sectors, electric
Bicycle Sharing Market Outlook 2032: Key Players Include Lime, Meituan Bike, Citi Bike, Nextbike, and Lyft
Bicycle Sharing Market Outlook 2032: Key Players Include Lime, Meituan Bike, Cit …
The bicycle sharing market is entering a phase of rapid transformation as urban mobility continues to evolve toward cleaner, smarter, and more efficient transportation alternatives. According to Persistence Market Research, the global bicycle sharing market is expected to be valued at US$ 10.1 billion in 2025, with projections indicating an expansion to US$ 20.1 billion by 2032, growing at a CAGR of 10.3% during the forecast period. This impressive growth
Low VOC Paints and Coatings Market Set to Grow from US$ 28.3 Billion in 2025 to US$ 36.7 Billion by 2032 - Persistence Market Research
Low VOC Paints and Coatings Market Set to Grow from US$ 28.3 Billion in 2025 to …
The global low VOC paints and coatings market is entering a significant stage of expansion fueled by rising environmental awareness, strict regulatory guidelines, and an increasing shift toward sustainable building materials. Modern consumers, manufacturers, and construction firms are focusing on healthier indoor environments, improved air quality, and reduced exposure to harmful chemicals. This has accelerated the adoption of low VOC paints and coatings across residential, commercial, and industrial applications. Get a
Engine Flush Market Outlook 2032: Key Players Include Liqui Moly, Valvoline, BASF, Motul, and 3M | Persistence Market Research
Engine Flush Market Outlook 2032: Key Players Include Liqui Moly, Valvoline, BAS …
The global engine flush market is entering a phase of steady expansion as consumers, fleet operators, and automotive service providers increasingly prioritize preventive maintenance and engine longevity. According to Persistence Market Research, the industry is projected to reach a value of US$1.8 billion in 2025 and further climb to US$2.4 billion by 2032, supported by a CAGR of 4.3% during the forecast period. The rising awareness of engine health, combined

All 5 Releases


More Releases for III

Ytterbium(III) Sulfate Market Size and Forecast
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- The global Ytterbium(III) Sulfate Market is expected to record a CAGR of XX.X% from 2024 to 2031 In 2024, the market size is projected to reach a valuation of USD XX.X Billion. By 2031 the valuation is anticipated to reach USD XX.X Billion. Ytterbium(III) Sulfate Market Size And Scope The Ytterbium(III) Sulfate market is projected to grow significantly, with a market size valued at approximately USD 110.3 million in
Iron(III) Isopropoxide Market 2024 Research Report
Iron(III) Isopropoxide Market The global Iron(III) Isopropoxide market was valued at US$ 62 million in 2023 and is anticipated to reach US$ 99 million by 2030, witnessing a CAGR of 7.0% during the forecast period 2024-2030. View Sample Report https://reports.valuates.com/request/sample/QYRE-Auto-10Y12819/Global_Iron_III_Isopropoxide_Industry_Research_Report_Growth_Trends_and_Competitive_Analysis_2022_2028 Report Scope The Iron(III) Isopropoxide market size, estimations, and forecasts are provided in terms of output/shipments (Gram) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the
What is Ruthenium III Chloride used for?
Ruthenium(III) chloride hydrate, also known as ruthenium trichloride hydrate, is a compound of great significance in various fields. This compound consists of ruthenium, chlorine and water molecules. With its unique properties, ruthenium(III) chloride hydrate has a wide range of applications in different industries. In this article, we explore the uses of ruthenium(III) chloride and emphasize its importance. Ruthenium(III) chloride hydrate is widely used as a catalyst in organic synthesis. It can
Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) Therapeutics - Pipelin …
Mucopolysaccharidosis type III (MPS III), also known as Sanfilippo syndrome, is a progressive disorder that primarily affects brain and spinal cord (central nervous system). People with MPS III generally do not display features at birth, but they begin to show signs and symptoms of this disorder during early childhood. Affected children often initially have delayed speech and behaviour problems. Download the sample report @ https://www.pharmaproff.com/request-sample/1146 In later stages of this disorder, people
Global Antithrombin III Deficiency Testing Market
The Antithrombin III Deficiency Testing Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. Antithrombin deficiencies are mainly divided into two types: type I and type II. The type I antithrombin deficiency is characterized by an inadequate amount of normal antithrombin present in
EXCEEMO Industrial SATA III SSD
Extremely impressive performance, the highest reliability and guaranteed fixed BOM - all in one service package for industrial customers EXCEEMO, the memory and storage specialist from Landsberg am Lech, presents the industrial 2.5“ SATA III Solid-State-Drives with ultra-fast read/write transfer speed of up to 555MB/515MB per second and proven long-term reliability. The noiseless, energy-efficient and particularly robust solid state drives are available both in standard grade (0°/+70°C-MLC/SLC) and in industrial